logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

The concept of weight loss pills continues to rise, Changshan Pharmaceutical's "20cm" limit up

date
11/07/2025
The concept of weight loss drugs continues to rise, Changshan Pharmaceutical's "20cm" limit up, Kaleen, Medisei, Jinkai Life Science, Borui Pharmaceutical, Norit Bio, Nanwei Technology and others follow the trend.
Latest
2 m ago
Huaxin Securities: Maintains "buy" rating on Jiangshan Stock, performance expected to continue to grow.
3 m ago
Huawei's new patent can be applied to four-fold devices.
3 m ago
Shenzhen Stock Exchange: After revision, there are 1316 sample stocks in the ChiNext Board, covering 95% of listed companies on the ChiNext Board.
4 m ago
The optimization of the ChiNext Comprehensive Index improves the quality of sample stocks and the investability of the index.
4 m ago
Datong Securities Zhejiang Branch Received Zhejiang Securities Regulatory Bureau Warning Letter.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.